SEARCH

SEARCH BY CITATION

References

  • 1
    Thom T, Haase N, Rosamond W, et al. Heart Disease and Stroke Statistics – 2006 Update. A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006;113:e85e151.
  • 2
    Gheorghiade M, Zannad F, Sopko G, et al. Acute heart failure syndromes: current state and framework for future research. Circulation. 2005;112:39583968.
  • 3
    Adams KF Jr, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149:209216.
  • 4
    Gheorghiade M, De LL, Fonarow GC, et al. Pathophysiologic targets in the early phase of acute heart failure syndromes. Am J Cardiol. 2005;96:11G17G.
  • 5
    Adamson PB, Magalski A, Braunschweig F, et al. Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system. J Am Coll Cardiol. 2003;41:565571.
  • 6
    Cleland JG, Coletta AP, Freemantle N, et al. Clinical trials update from the American College of Cardiology meeting: CARE-HF and the remission of heart failure, Women’s Health Study, TNT, COMPASS-HF, VERITAS, CANPAP, PEECH and PREMIER. Eur J Heart Fail. 2005;7:931936.
  • 7
    Fonarow GC. Overview of acutely decompensated congestive heart failure (ADHF): a report from the ADHERE Registry. Heart Fail Rev. 2004;9:179185.
  • 8
    Fonarow GC, Adams KF Jr, Abraham WT, et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. 2005;293:572580.
  • 9
    Fonarow GC, Yancy CW, Heywood JT. Adherence to heart failure quality-of-care indicators in US hospitals: analysis of the ADHERE Registry. Arch Intern Med. 2005;165:14691477.
  • 10
    Cleveland W. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc. 1979;74:829836.
  • 11
    Abraham WT, Adams KF, Fonarow GC, et al. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol. 2005;46:5764.
  • 12
    Publication Committee for the VMAC Investigators (Vasodilation in the Management of Acute Heart CHF). Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA. 2002;287:15311540.
  • 13
    Gheorghiade M, Gattis WA, O’Connor CM, et al. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. JAMA. 2004;291:19631971.
  • 14
    Mebazaa A. The SURVIVE-W Trial: Comparison of Dobutamine and Levosimendan on Survival in Acute Decompensated Heart Failure [abstract]. American Heart Association Scientific Sessions 2005; Presented November 16, 2005.
  • 15
    Packer M. REVIVE II: Multicenter Placebo-Controlled Trial of Levosimendan on Clinical Status in Acutely Decompensated Heart Failure [abstract]. American Heart Association Scientific Sessions 2005; Presented November 14, 2005.
  • 16
    Teerlink JR, McMurray JJ, Bourge RC, et al. Tezosentan in patients with acute heart failure: design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS). Am Heart J. 2005;150:4653.
  • 17
    Cuffe MS, Califf RM, Adams KF Jr, et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. 2002;287:15411547.
  • 18
    DiDomenico RJ, Park HY, Southworth MR, et al. Guidelines for acute decompensated heart failure treatment. Ann Pharmacother. 2004;38:649660.
  • 19
    Johnson W, Omland T, Hall C, et al. Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure. J Am Coll Cardiol. 2002;39:16231629.
  • 20
    Butler J, Forman DE, Abraham WT, et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J. 2004;147:331338.
  • 21
    Hasselblad V, Stough WG, Shah MR, et al. Relation between diuretic dose and outcome in a heart failure population: results of the ESCAPE trial [abstract]. J Card Fail. 2005;11:S157.